Swiss startup Atlas Bio secures $12.5M to tackle drug development’s 70% failure rate and move beyond animal testingSwiss tech-bio firm Atlas Bio today launched from stealth with a $10 million Seed round led by Creandum, alongside a previously unannounced pre-Seed round led by First Momentum Ventures and LEA Partne...Tech.eu · 2026-10-27T13:00:00.000Z